Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
36.69Prev. Close
35.98Volume
2,75,398Total traded value
1.03 CrUpper Circuit
43.17Lower Circuit
28.78Fundamentals
| Market Cap | ₹199Cr |
| ROE | 6.09% |
| P/E Ratio(TTM) | 13.68 |
| EPS(TTM) | 2.63 |
| P/B Ratio | 0.83 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.24 |
| Book Value | 43.12 |
| Debt to Equity | 0.24 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Balaxi Pharma
Balaxi Pharma is a global pharmaceutical company making affordable generic and branded generic medicines accessible in frontier markets across Latin America and Africa. The company's purpose is to bring high-quality everyday medicines within reach of these populations, creating sustainable value for all stakeholders. It has an impressive portfolio with 960 registered products across multiple countries and is committed to expanding its market presence.;
| Parent Organisation | Balaxi Pharmaceuticals Limited |
| Managing Director | Mr. Ashish Maheshwari |
| NSE Symbol | BALAXI |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.02 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 31.55 | ||
| Cohance Lifesciences | NA (0.00%) | 71.04 | ||
| Wockhardt | NA (0.00%) | -421.94 |